ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,867.08
0.00%
US Tech 100
20,411.20
-0.76%
Dow Jones
42,342.24
0.00%
Brent Oil
72.185
-0.28%
Bitcoin
94,868.98
-2.64%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. NEO

  6. Abbvie CDR (ABBV) Quote

Abbvie CDR

Abbvie CDR (ABBV)

AbbVie Inc
24.78
0.00
(0.00%)
Closed December 20 4:00PM
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
24.78
Bid
24.66
Ask
24.74
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
24.78
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

Ask ADVFN Intelligence (AI)

ABBV Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

December 18 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

December 16 2024
Edgar (US Regulatory)

Form 8-K - Current report

December 13 2024
Edgar (US Regulatory)

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline PR Newswire NORTH CHICAGO, Ill. and MADISON, Wis., Dec. 13, 2024 Proposed acquisition adds Nimble's lead asset, an...

December 13 2024
PR Newswire (US)

AbbVie Completes Acquisition of Aliada Therapeutics

AbbVie Completes Acquisition of Aliada Therapeutics PR Newswire NORTH CHICAGO, Ill., Dec. 11, 2024 Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease...

December 11 2024
PR Newswire (US)

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma

Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell...

December 09 2024
PR Newswire (US)

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease PR Newswire NORTH CHICAGO, Ill., Dec. 9, 2024 Tavapadon met...

December 09 2024
PR Newswire (US)

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients PR Newswire NORTH CHICAGO, Ill., Dec. 8, 2024 -New insights show Black, Hispanic, and Asian...

December 08 2024
PR Newswire (US)

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) PR...

December 07 2024
PR Newswire (US)

AbbVie to Present at Citi's 2024 Global Healthcare Conference

AbbVie to Present at Citi's 2024 Global Healthcare Conference PR Newswire NORTH CHICAGO, Ill., Nov. 25, 2024 NORTH CHICAGO, Ill., Nov. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will...

November 25 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABBV - Frequently Asked Questions (FAQ)

What is the current Abbvie CDR share price?
The current share price of Abbvie CDR is $ 24.78
What is the 1 year trading range for Abbvie CDR share price?
Abbvie CDR has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.

Discussion

View Full Feed
Jahvik Jahvik 2 minutes ago
https://x.com/secmattersltd/status/1870066057215430960?s=42
HMBL
maddyandboomer maddyandboomer 2 minutes ago
I think they will keep raising a half biillion at a time until 5 billion and then reverse it
AXXA
TURCH TURCH 2 minutes ago
Nice!


Regards
INVZ
Doc logic Doc logic 3 minutes ago
flipper44,

In my opinion, the company would be foolish to allow someone to sign an NDA in order to do what you are wondering about. Too easy for MHRA and NWBO to end up being put in a bad position with any news leaked out before a final decision and no one is going to do anything wit
NWBO
Z06 MAN Z06 MAN 4 minutes ago
LMAO… Wrong… Keep trying to spread your FUD!



$$KBLB$$
KBLB
linkvest linkvest 4 minutes ago
Sorry it wasn't me who painted yesterday at closing but I did buy Millions and Millions of ASII yesterday..
ASII
peanutz peanutz 4 minutes ago
We are almost through the End of year sell-off. New Year we move up !
RDAR
RickNagra RickNagra 5 minutes ago
I put KC and his Sunshine Band on ignore ten years ago.  That includes Bradturd.
FNMA
jimr1717 jimr1717 5 minutes ago
I would think that you should have made Tom Kanes Christmas card list
PCTL
Robert31 Robert31 5 minutes ago
There's a reason for that, the past looks better than the current future forecast.
SEV
ddls ddls 5 minutes ago
Ask Warren is he likes BIEL.😎
BIEL
hweb2 hweb2 5 minutes ago
Poor Q4 comp on CSPI as I feared. Looks like stock going to get whacked today. Hopefully the CC later goes well. AZT PROTECT was launched in 2023 right? At some point that potential has to translate into revenues...over a year later and it still hasn't...so not great.
RMS555 RMS555 5 minutes ago
The CEO of PSRU (Xavier Mitchell) is a WANNABE, plain and simple!!!!

PSRU IS A SCAM , the "top traders" know this........ Xavier Mitchell is a WANNABE!


.
PSRU
werd werd 6 minutes ago
I can see them both I've had that happen when I got too detailed facts. It's on topic because it's about this ticker. 
GTCH
RKhan2011 RKhan2011 6 minutes ago
Tru dat! Appreciate the info 🙏🏿 imagine if there wasn't RS we'd be millionaires 🤣🤷🏾‍♂️
IHGP
al44 al44 6 minutes ago
Texas's governor, Greg Abbott, ahead of the curve ... again

By Monica Showalter


It raises questions as to why the Biden administration never bothered doing this -- and we all know why they didn't. They were too busy Letting Them In. They had a political interest
sharkey1 sharkey1 6 minutes ago
we already captured
https://www.youtube.com/watch?v=5pMeb4ZSHh8
5%
ELTP
BIOChecker4 BIOChecker4 6 minutes ago
The only time I’ve been wrong about anything I’ve said was when Anavex filed the EMA in the current year, and when that happened I offered my congratulations.

You and a handful of others have a serious problem with anybody who dares to voice any opinions that contradicts the approved
AVXL
straightword straightword 6 minutes ago
Where's the .85 that you've been predicting for the last year? LOL!!
VPLM
penguin007 penguin007 7 minutes ago
I read an interesting article the other day, it was suggesting that XRP should be valued at approximately 12% of BTC's value today. Wouldn't that be something, to actually live to see a correction in XRP price that reflects anything remotely close to that value. Just a thought.
XRPUSD
edbi46 edbi46 7 minutes ago
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 10 years since Oct. 2015 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!

ATTENTION all the Respected, Smart, Intelligent Inves
MCF WBA
flipper44 flipper44 7 minutes ago
Actually, you are the twit isolating posters and ignoring just plain sequential occurrences. OMG, you’re a censor. :-)

A 7.2 million outstanding share reversal is as yet unexplained. There are several possible reasons for it.
NWBO
Richie Rich Richie Rich 7 minutes ago
i understand a lot of got messed over, thanks again to D.E.'s hype, but I saw their product still for sale on an online store. They won't answer their phones. I didn't know if I should relinquish my shares as a loss for my taxes or hold on for a miracle down the road.
PCTL

Your Recent History

NEO
ABBV
Abbvie CDR
NYSE
BRC
Brady
AMEX
UVIX
2x Long VIX Futures ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads